EUVIMEDEUVIMED entdecken
Open Access

Intradiscal Injections of Bone Marrow Concentrate or Leukocyte-Rich Platelet-Rich Plasma for the Treatment of Cervical Discogenic Pain: A Case Series

John Pitts, Jason Markle, Dustin Berger, Ehren Dodson

Cureus · 15.05.2025

DOI: 10.7759/cureus.84166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 15.05.2025. Verfasst von John Pitts und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Pain Management, Centeno-Schultz Clinic, Broomfield, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cervical discogenic pain is a prevalent and debilitating condition. In recent years, autologous regenerative therapies such as bone marrow concentrate (BMC) and platelet-rich plasma (PRP) have gained attention as potential alternatives to traditional interventional pain management. This study investigates the safety and efficacy of these treatments when delivered intradiscally as part of a comprehensive cervical functional spinal unit (FSU) approach. METHODS: This is a retrospective case series utilizing registry data, with 18 participants meeting the inclusion criteria. Intradiscal injections of BMC or leukocyte-rich PRP were guided by ultrasound and fluoroscopy with contrast confirmation. Patient-reported outcome measures (PROMs), including the Functional Rating Index (FRI), Numeric Pain Scale (NPS), and a modified Single Assessment Numeric Evaluation (SANE), were collected at baseline and at a minimum of three months post-treatment, with a mean follow-up of one year. RESULTS: Eleven participants received BMC injections, and seven received leukocyte-rich PRP injections. No adverse events were reported during the study period. Statistical analysis revealed a significant reduction in the NPS in half of the patients (9 of 18) (mean difference = -1.0, P = 0.024), while a majority (14 of 18) reported improvement in FRI scores (mean difference = -10.9, P = 0.015). The average SANE score was 60%, with most patients (14 of 18) reporting 50% or greater improvement. CONCLUSION: Intradiscal injections of BMC or LR-PRP as part of a comprehensive cervical FSU approach appear to be safe and effective for improving patient-reported pain and function. These findings support the potential of autologous biologics as an alternative treatment modality for cervical discogenic pain.

Schlagwörter

Stichwörter der Autor:innen

bone marrow concentrate (bmc)cervical intradiscalfunctional spinal unit (fsu)interventional pain managementneck painorthobiologicsplatelet lysate (pl)platelet-rich plasma (prp)regenerative medicine therapies

Autor:innen und Institutionen

  • Interventional Pain Management, Centeno-Schultz Clinic, Broomfield, USA.
  • Physical Medicine and Rehabilitation, Interventional Orthopedics and Regenerative Medicine, Centeno-Schultz Clinic, Broomfield, USA.
  • Research and Development, Regenexx, Broomfield, USA.

Zitieren

APA

Pitts, J., Markle, J., Berger, D., & Dodson, E. (2025). Intradiscal Injections of Bone Marrow Concentrate or Leukocyte-Rich Platelet-Rich Plasma for the Treatment of Cervical Discogenic Pain: A Case Series. Cureus. https://doi.org/10.7759/cureus.84166

Vancouver

Pitts J, Markle J, Berger D, Dodson E. Intradiscal Injections of Bone Marrow Concentrate or Leukocyte-Rich Platelet-Rich Plasma for the Treatment of Cervical Discogenic Pain: A Case Series. Cureus. 2025. doi:10.7759/cureus.84166

BibTeX
@article{Pitts2025,
  author = {Pitts, John and Markle, Jason and Berger, Dustin and Dodson, Ehren},
  title = {Intradiscal Injections of Bone Marrow Concentrate or Leukocyte-Rich Platelet-Rich Plasma for the Treatment of Cervical Discogenic Pain: A Case Series},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.84166}
}
Kostenlos starten →